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MaValve stress echocardiography (VSE) is increasingly used both within specialist valve clinics and within dedicated VSE
services, mandating practical guidance for referral, procedure, reporting, and clinical implementation of results. There-
fore, a didactic VSE guide was compiled based on current European Society of Cardiology and American College of
Cardiology/American Heart Association valve disease management guidelines, review of existing evidence, and the
authors’ extensive experience with VSE. The VSE indications were grouped into 3 categories: symptoms despite nonse-
vere valve disease, asymptomatic severe valve disease, and valve disease with reduced left ventricular systolic function.
The aim of the test, the type of stress to be used, the sequence of image acquisition, the information to be included in the
report, and the implication of the VSE results for clinical management were described for every indication and summa-
rized in user-friendly tables. (J Am Coll Cardiol Img 2015;8:724–36) © 2015 by the American College of Cardiology
Foundation.I n patients who have asymptomatic severe valvedisease, exercise testing is an established prac-tice to detect occult symptoms (1–5). However,
additional diagnostic and prognostic information
can be obtained by adding echocardiographic imaging
to exercise testing or to dobutamine infusion, in a
wider range of indications (1–3,6). Valve stress echo-
cardiography (VSE) is being increasingly used, both
within the specialist valve clinics and within dedi-
cated VSE services receiving referrals from cardiolo-
gists and cardiac surgeons outside the boundaries of
the specialist valve clinic. To aid in this evolving clin-
ical practice, and mirroring routine in the authors’
own departments, the current paper presents a di-
dactic guide for VSE procedures and reporting and
also for VSE referral and interpretation of results;
the information is based on guidelines, recommenda-
tions, referenced current evidence, and the authors’
experience. The HAVEC (Heart Valve Clinic Interna-
tional Database) group recognized the need for
concerted efforts to enhance the VSE evidence basem the *King’s Health Partners, King’s College Hospital NHS Foundatio
ntre, Guy’s and St. Thomas’ Hospital, London, United Kingdom; zMar
lanta, Georgia; xUniversity of Liège Hospital, GIGA Cardiovascular Scien
U Sart Tilman, Liège, Belgium; and kGVM Care and Research, Lugo (RA),
t sponsored) who have put together a collection of prospectively collect
HAVEC have facilities to diagnose and regularly monitor patients with
t they have no relationships relevant to the contents of this paper to dis
nuscript received January 6, 2015; revised manuscript received January 2before the update of current valve disease manage-
ment guidelines to reﬂect expert practice trends.
REFERRAL GUIDE
The VSE indications can be classiﬁed into 3 cate-
gories: symptoms despite nonsevere valve disease,
asymptomatic severe valve disease, and valve disease
with reduced left ventricular (LV) systolic function.
Throughout the text, the references associated with
each indication denote whether the indication is
well established and generally accepted, being
consequently included in current European Society of
Cardiology (ESC) and American College of Cardiology
(ACC)/American Heart Association (AHA) guidelines
(1,2) and recommendations (7), or is not well estab-
lished but supported by some more recent evidence.
Comments lacking a reference represent the opinion
of the authors. The VSE indications’ acceptance
status and evidence have been summarized (Table 1)
to highlight the gap between current trends andn Trust, London, United Kingdom; yCardiothoracic
cus Heart Valve Center, Piedmont Heart Institute,
ces, Departments of Cardiology, Heart Valve Clinic,
Italy. The HAVEC group is composed of volunteers
ed data on valvular heart disease. Centers involved
valvular heart disease. The authors have reported
close.
2, 2015, accepted February 12, 2015.
TABLE 1 VSE Indications’ Acceptance Status and Supportive Evidence
VSE Indication ESC ACC/AHA Evidence (Ref. #) Expert Practice
Symptomatic patient
Nonsevere MR Yes Yes (6,8,9,11) Yes
Pulmonary edema Yes No (8) Yes
Mild MR before CABG Yes No (10) Yes
Nonsevere MS Yes Yes (6,8,11,13–19) Yes
Nonsevere AR No Yes* No Yes†
Nonsevere AS Yes Yes (8,11,13,20,21,41) Yes
Paradoxical low-ﬂow AS Yes Yes (8,11,22,23) Yes
Equivocal AV PPM/stenosis Yes Yes (7,8,11,24) Yes
Equivocal MV PPM/stenosis Yes Yes (7,8,11) Yes
Asymptomatic patient
Severe MR Yes Yes (6,8,11,25–28) Yes
Signiﬁcant MS Yes Yes (6,8,11,13–19) Yes
Severe AR No Yes* (29,30) Yes
Severe AS Yes Yes (3–5,8,11,13,20,21,31–37,39) Yes
Low LVEF
Low-ﬂow AS Yes Yes (8,11,23,38–45,47,48) Yes
Low-ﬂow AV prosthesis No No No Yes
*Exercise test only. †Exercise echocardiogram to assess existence of inducible ischemia.
ACC ¼ American College of Cardiology; AHA ¼ American Heart Association; AR ¼ aortic regurgitation; AS ¼
aortic stenosis; AV ¼ aortic valve; CABG ¼ coronary artery bypass grafting; ESC ¼ European Society of Cardi-
ology; LVEF ¼ left ventricular ejection fraction; MR ¼ mitral regurgitation; MS ¼ mitral stenosis; MV ¼ mitral
valve; PPM ¼ patient–prosthesis mismatch; VSE ¼ valve stress echocardiography.
AB BR E V I A T I O N S
AND ACRONYM S
ACC = American College of
Cardiology
AHA = American Heart
Association
AR = aortic regurgitation
AS = aortic stenosis
CABG = coronary artery bypass
grafting
ESC = European Society of
Cardiology
LV = left ventricular
MR = mitral regurgitation
MS = mitral stenosis
SPAP = systolic pulmonary
arterial pressure
VSE = valve stress
cardiography
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725guidelines. The goal of the test depends on the VSE
indication (Table 2).
SYMPTOMS DESPITE NONSEVERE VALVE DISEASE.
Exertional breathlessness, chest pain, or unexplained
acute pulmonary edema requires revaluation of valve
disease severity based on ﬂow-dependent changes or
on its dynamic component (1,2).
Mitral regurgitation. Secondary mitral regurgitation
(MR) as a result of ischemic heart disease is likely to
worsen on exertion, but this outcome can occur for
any MR etiology (1,2,8,9). In patients with unex-
plained acute pulmonary edema (1,8), stress may
induce myocardial ischemia with associated dynamic
ischemic MR.
Mild MR is an indication for exercise VSE before
coronary artery bypass grafting (CABG), as suggested
by evidence from the RIME (Randomized Ischemic
Mitral Evaluation) trial (10). This trial found that
mitral annuloplasty at the time of CABG in patients
with moderate ischemic MR at rest or developed on
exertion might improve functional capacity, LV
reverse remodeling, MR severity, and B-type natri-
uretic peptide levels. The ESC guidelines (1) recom-
mend mitral valve surgery at the time of CABG in
patients with moderate MR and use of VSE to assess
symptoms and exertion-induced MR severity and
systolic pulmonary arterial pressure (SPAP) increases.
Mitral stenosis. A noncompliant mitral valve may
be moderately stenotic at rest but hemodynami-
cally severely stenotic during stress, as it fails to
open further to accommodate the increase in ﬂow
(1,2,6,11–15). In addition, because indexed valve area
thresholds are not deﬁned, VSE may be useful for
grading mitral stenosis (MS) in patients with a
large body surface area (13). Gradient thresholds
(1,2,11,16–19) for severe MS have been established as
>15 mm Hg on exertion or >18 mm Hg during
dobutamine infusion. In addition, SPAP >60 mm Hg
on exertion (1,2,11,18) suggests severe MS. Proof of
hemodynamic signiﬁcance may help clinical decision-
making in cases of valve morphology not suitable for
balloon valvotomy and those of high surgical risk.
Furthermore, even in cases of valve morphology
suitable for balloon valvotomy, proof of increases in
mean gradient and increases in SPAP to >60 mm Hg
during VSE strengthens the decision to proceed if the
MS is only moderate at rest.
Aortic regurgitation. Aortic regurgitation (AR) is re-
duced at high heart rates as diastole shortens even if
the systemic pressure rises. Consequently, although
exercise testing is recommended to conﬁrm equivocal
symptoms (2), echocardiographic imaging can only be
added with the goal of revealing inducible myocardialischemia but not with the goal of re-grading
AR severity.
Aortic stenosis. As with MS, a noncompliant
aortic valve may be moderately stenotic at
rest but severely stenotic during stress (20,21)
because the valve fails to open further.
Consequently, gradient increase and calcu-
lated functional valve area failure to increase
during VSE suggest severe aortic stenosis (AS)
(5,8,11,13,20,21). VSE is indicated (1,2) to re-
grade AS severity in symptomatic patients.
Furthermore, because coexistence of coro-
nary artery disease is common in calciﬁc AS,
the VSE may also detect inducible ischemia.
VSE may help grade AS severity in para-
doxical low-ﬂow AS (22,23). Dobutamine
should be used with caution and could be
potentially contraindicated if (as is common
in paradoxical low-ﬂow AS) the LV has severe
hypertrophy, especially of the basal interventricular
septum and small cavity, because of the high likeli-
hood of dobutamine-induced left ventricular outﬂow
tract (LVOT) obstruction and drop in blood pressure
during the test.
Prosthetic valves. A VSE is recommended to help
diagnose an obstructive prosthetic valve (7). A sig-
niﬁcant mean gradient rise (for both aortic and mitral
prosthetic valves) (16,24) and a calculated functional
valve area failure to rise (for aortic prosthetic valves)
echo
TABLE 2 VSE Aim According to Indication
Aim of the Test
Symptomatic patient
Nonsevere MR Query exertion induced MR severity rise  SPAP rise >60 mm Hg  LVEF failure to rise by at least 4% to
explain symptoms
Pulmonary edema Query inducible ischemia and dynamic ischemic MR
Mild MR before CABG Query exertion-induced MR severity rise  SPAP rise >60 mm Hg
Nonsevere MS Query exertion-induced mean gradient >15 mm Hg  SPAP >60 mm Hg  rise in MR severity or
dobutamine-induced mean gradient >18 mm Hg to explain symptoms
Nonsevere AR Query coexistent abnormalities (e.g., inducible ischemia), LVEF failure to rise, and/or SPAP rise
to >60 mm Hg on exertion
Nonsevere AS Query coexistent abnormalities (e.g., inducible ischemia) and mean gradient rise and calculated
AV area failure to increase with ﬂow to explain symptoms
Paradoxical low-ﬂow AS Query severe AS assessing transvalvular gradient and calculated AV area changes with increase in ﬂow
Equivocal AV PPM/stenosis Query severe PPM/stenosis assessing transvalvular gradient and calculated valve area changes with
increase in ﬂow
Equivocal MV PPM/stenosis Query severe PPM/stenosis assessing transvalvular gradient and calculated valve area changes with
increase in ﬂow
Asymptomatic patient
Severe MR Query exercise tolerance and symptoms  SPAP rise >60 mm Hg, LVEF failure to rise by at least
4%  global longitudinal strain failure to rise by –2%
Signiﬁcant MS Query exercise tolerance and symptoms  mean gradient rise >15 mm Hg  SPAP rise >60 mm Hg
Severe AR Query exercise tolerance and symptoms  contractile reserve
Severe AS Query exercise tolerance and symptoms  SBP drop or failure to rise by 20 mm Hg, ST-segment depression,
RWMA, contractile reserve, LV longitudinal function, SPAP rise >60 mm Hg, mean gradient
rise >18–20 mm Hg
Low LVEF
Low-ﬂow AS Query LV ﬂow reserve and gradient þ calculated AV area changes with increase in ﬂow
Low-ﬂow AV prosthesis Query LV ﬂow reserve and gradient þ calculated valve area changes with ﬂow
LV ¼ left ventricular; RWMA ¼ regional wall motion abnormality; SBP ¼ systolic blood pressure; SPAP ¼ systolic pulmonary arterial pressure; other abbreviations as in Table 1.
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726with associated reproduction of symptoms during
VSE suggest that an obstructive valve is the cause of
symptoms (patient–prosthesis mismatch or prosthesis
stenosis). A mean gradient rise is signiﬁcant if it is at
least >20 mm Hg for prosthetic aortic valves and at
least >12 mm Hg for prosthetic mitral valves (11). In
cases of an obstructive prosthetic aortic valve, the
VSE may also reveal inducible ischemia or signiﬁcant
exertion-induced MR (7). In cases of an obstructive
prosthetic mitral valve, the VSE may also reveal an
exertion-induced SPAP increase to >60 mm Hg.
ASYMPTOMATIC SIGNIFICANT VALVE DISEASE. The
main goal of VSE is to detect occult symptoms
because they are an indication for surgery, as with
spontaneously reported symptoms (1,2). The test can
be performed with treadmill or bicycle exercise. The
addition of echocardiography to exercise test data
may add diagnostic and prognostic beneﬁt.
Severe primary MR. In patients with repairable valves
at low surgical risk, symptoms (1,2) and/or SPAP
>60 mm Hg (1) during exercise testing (6,25)
strengthen the argument for surgery. There is also
evidence that the exercise VSE-demonstrated lack of
contractile reserve (failure to increase the left ven-
tricular ejection fraction [LVEF] by >4% [26] or theglobal longitudinal strain by –2% [27,28]) confers poor
prognosis.
Signiﬁcant MS. In MS with a valve area <1.5 cm2 but
>1 cm2 (deﬁned as moderate but signiﬁcant in the ESC
guidelines and deﬁned as severe in the ACC/AHA
guidelines), VSE is indicated before major noncardiac
surgery or pregnancy planning (1,8). During routine
surveillance, VSE can be considered (6,14–16) in MS
with a valve area <1.5 cm2 but >1 cm2 if the valve is
suitable for balloon valvotomy (2) or in MSwith a valve
area <1 cm2 (deﬁned as severe in the ESC guidelines)
if the valve is unsuitable for valvotomy (1,2).
Severe AR. Exercise testing is indicated to uncover
symptoms (2) because of the high mortality implied.
Exercise VSE allows for assessment of LV contractile
reserve, the lack of which predicts the development
of LV systolic dysfunction at follow-up or post-
operatively (8,29). Longitudinal function at rest and
on exertion may also aid in the detection of early LV
systolic dysfunction (8,30).
Severe AS. Exercise testing is recommended in these
patients with severe AS (1,2). Ventricular arrhythmia,
systolic blood pressure drop or failure to rise by
20 mm Hg, ST-segment depression, induced regional
wall motion abnormalities, reduced contractile
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727reserve, impaired rest or exertion LV longitudinal
function (31), SPAP >60 mm Hg (32), and develop-
ment of angina, breathlessness, pre-syncope, or syn-
cope characterize an abnormal exercise response
(8,33–35). Mean gradient increases >18 to 20 mm Hg
suggest a poor prognosis (1,36,37). Caution regarding
exercise testing is recommended in cases of AS with
peak velocity >5 m/s or mean gradient >60 mm Hg,
which in cases of low surgical risk represent a Class
IIa surgical indication in both the ACC/AHA (1) and
the ESC (2) guidelines; the ESC guidelines allow for a
higher peak velocity (5.5 m/s).
VALVE DISEASE WITH REDUCED LV SYSTOLIC
FUNCTION. Low-ﬂow, low-gradient AS. VSE is recom-
mended for grading of AS severity and for assessment
of ﬂow reserve when the LVEF is <50% (1,2). Mean
gradient increase and calculated functional valve area
failure to increase during VSE suggest severe AS. The
existence of ﬂow reserve is diagnosed when there is
an increase in stroke volume or LVOT velocity time
integral by >20% (8,20,23,38–44).
Low-ﬂow aortic valve prosthesis. As for low-ﬂow,
low-gradient AS, VSE may be used for prosthesis
dysfunction grading in symptomatic patients.
Although VSE indications are continuously
evolving and there is still need for further evidence in
many aspects of the test, there is no indication or
there is even contraindication for VSE in some clinical
scenarios. VSE is contraindicated in symptomatic
patients with severe disease, both because these
clinical scenarios indicate intervention and because
of the risk associated with the test, particularly for
those with severe AS (1,2). There is no indication for
VSE, due to futility, in patients unsuitable for inter-
vention. There is also no indication for VSE in
asymptomatic patients with mild or moderate disease
in whom the test results would not affect clinical
management.
PROCEDURE GUIDE
There is limited information in the published data
regarding practical aspects of the VSE procedure.
Therefore, this procedure guide is mainly based on
the experience of the authors.
TYPE OF STRESS. Depending on clinical indication,
the VSE is performed with exercise or dobutamine
(Table 3).
Exercise VSE. Exercise is physiological and can be used
to assess symptoms and exercise tolerance, and it is
the stressor of choice in asymptomatic severe valve
disease. Although dobutamine has been used in
asymptomatic severe AS to assess the valvecompliance to ﬂow (16), it is usually contraindicated
in severe AS because it can precipitate life-threatening
hypotension and pulmonary edema in case the valve
area is ﬁxed, limiting the increase in forward ﬂow.
Consequently, exercise remains the stressor of choice
when severe AS is diagnosed at rest (1,2,8,31–37). In
addition, only exercise VSE provides information
regarding dynamic SPAP changes (1,2,11,18). Further-
more, due to complex interference of dobutamine
effects with MRmechanisms, only exercise VSE can be
used for MR assessment (1,2,8–10).
Dobutamine VSE. Dobutamine-induced inotropic re-
cruitment is currently the only VSE method recom-
mended for assessment of low-ﬂow, low-gradient AS
(1,2,8,20,23,38–44). This sole recommendation is
because of concerns that symptoms or a low exercise
tolerance in asymptomatic sedentary patients can
limit the exercise-induced contractile recruitment,
consequently preventing the correct assessment of
both stenosis severity and ﬂow reserve. Nevertheless,
some patients, particularly asymptomatic, physically
active patients with incidental low-ﬂow, low-gradient
AS, might potentially achieve the target workload
(20% increase in LVOT–derived stroke volume),
which allows for a correct diagnosis (8,20,23,38–44).
An exertion-induced increase in stroke volume,
demonstrating the existence of ﬂow reserve with an
associated rise in calculated functional AV area, sug-
gests target workload and test endpoint achievement.
It is the opinion of the current writing group that a
dobutamine test can be avoided in this case. How-
ever, if the achieved workload is low, with an
apparent lack of ﬂow reserve, the test should be
repeated with dobutamine.
STRESS PROTOCOL. Exerc ise . Treadmill exercise
testing can be used for VSE. Nevertheless, the authors
favor supine bicycle exercise testing for VSE because
treadmill exercise has the major disadvantage of
allowing only pre- and post-stress image acquisition.
Consequently, because changes in recorded parame-
ters are transient, immediately decreasing with
cessation of exercise and being short-lasting, conse-
quences of exercise can be underestimated or even
missed. Furthermore, post-treadmill image acquisi-
tion does not allow for timing of events, apprecia-
tion of sequence of events, or acquisition of images
at low workload, thus potentially concealing impor-
tant information. For example, although SPAP in-
creases often on exertion, an early rise at low
workload is more speciﬁc for a pathological
response. Regarding sequence of events, whereas
low LV systolic function at peak (or post-peak) ex-
ercise may signify a lack of contractile reserve, an
TABLE 3 Type of Stress Used According to VSE Indication
Exercise Only Exercise or Dobutamine Dobutamine Only
Symptomatic patient Symptomatic patient Symptomatic patient
Nonsevere MR Pulmonary edema
Mild MR before CABG Nonsevere MS
Nonsevere AR Paradoxical low-ﬂow AS
Nonsevere AS
Equivocal AV PPM/stenosis
Equivocal MV PPM/stenosis
Asymptomatic patient Asymptomatic patient Asymptomatic patient
Severe MR Moderate MS
Severe MS
Severe AR
Severe AS
Low LVEF Low LVEF Low LVEF
Low-ﬂow, low-gradient AS
Low-ﬂow AV prosthesis
Abbreviations as in Table 1.
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728initial increase in LV systolic function at low work-
load followed by a drop at high workload suggests
the existence of inducible ischemia rather than a
lack of contractile reserve (45). Treadmill exercise
excludes image acquisition at low workload, when
contractility recruitment is achieved but the heart
rate remains below forbidden levels (100 to 110
beats/min) for some modalities (i.e., 3-dimensional
echocardiography for LV contractile reserve).
Supine bicycle exercise allows image acquisition at
any stage during the VSE. Exercise protocols can be
designed and programmed on an electronic bicycle,
or they can be manually adjusted for each patient’s
needs. The workload should be initially low (0, 25, or
50 W depending on patient’s age, expected exercise
tolerance, and pathology) and then increased in
steps, usually by 25 W every 2 min. A more gradual
increase in workload can be used for assessment of
exercise tolerance or contractile reserve; neverthe-
less, a higher workload rather than a longer exertion
time more likely reveals severity of pathology,
particularly MR and SPAP increases.
The predicted maximum workload for healthy
subjects is 2.5 W/kg in women and 3.0 W/kg in men
between 21 and 30 years of age, minus 10% for each
added decade. The workload achieved depends not
only on severity of valve disease but also on the
patient’s exercise habits and familiarity with the
test. Prolonging the test by starting with a too-low
workload for a certain patient may result in a lower
achieved maximum workload. Starting with a too-
high workload may discourage the patient from
completing the test.Dobutamine. A low-dose dobutamine infusion proto-
col is used for grading of AS severity, with 5-min
stages and incremental doses of 5, 10, 15, and
20 mg/kg/min. The test is terminated when the target
increase in ﬂow (20% increase in LVOT–derived
stroke volume) is achieved (8,20,23,38–44); a dobut-
amine dose of 10 mg/kg/min is usually sufﬁcient.
A high-dose dobutamine infusion protocol is
used in patients with a history of unexplained pul-
monary edema in the absence of severe AS, with
3-min stages and incremental doses of 5, 10, 20, 30,
and 40 mg/kg/min. The same protocol is used for
grading of MS severity (6,8,11,14–19), with the test
being terminated if a mean gradient suggestive of
severe stenosis develops.
PRE-TEST REQUIREMENTS. Heart rate–limiting drugs
with inotropic negative effects are stopped before VSE
to assess contractile reserve, ﬂow reserve, parameters
depending on enhanced contractility (e.g., aortic valve
gradients), or exercise tolerance. To avoid excessive
increases in heart rate, exceptions can be made for
patients in chronic atrial ﬁbrillation. Heart rate–
limiting drugs are not stopped before VSE when the
goal is to assess exertion-induced changes in mitral
valve Doppler ﬂow parameters.
For exercise VSE, patients are asked not to eat for
2 h and not to drink for 1 h before the test; this is
because supine exercise is more comfortable on an
empty stomach. Height and weight are measured
before the test to calculate body surface area for
indexed measurements, the predicted workload, or
the dose of dobutamine.
IMAGE ACQUISITION PROTOCOL. Dedicated image
acquisition protocol templates can be created on the
echocardiography machines for every indication, to
act as a reminder, and to reproduce rest settings
during exercise. Nevertheless, templates may be
restrictive during the test in cases of unexpected
developments that dictate off-protocol imaging. Free
image acquisition is usually preferred.
The sequence of image acquisition depends on the
VSE indication; it should always commence with
images essential for diagnosis to ensure that these
images at a minimum have been acquired in case the
test is suddenly terminated because the patient stops
cycling or a complication occurs. For example, in the
case of severe MR, the tricuspid regurgitation
continuous Doppler for SPAP estimation and the LV
images are ﬁrst acquired because decision-making
depends on SPAP rise and LV contractile reserve.
Conversely, in cases of mild or moderate MR sus-
pected to increase on exertion, color and continuous
wave Doppler ﬂow images will be acquired ﬁrst.
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729The sequence of image acquisition for a minimum
dataset according to VSE indication is displayed in
Table 4.
Images should be acquired at least at baseline, low
workload, and peak during exercise VSE and at the
end of every stage during dobutamine VSE. For both
stress modalities, we advise almost continuous live
imaging if transient changes are likely. For example,
in the case of low-ﬂow AS, an initial contractile
recruitment–related rise in LVOT and transvalvular
velocities can be transient and followed by an
ischemia-related reduction in systolic function, with
a consequent drop in velocities.
At low workload, the main parameters to be
assessed are SPAP and LV systolic function, with
particular signiﬁcance for some VSE indications. For
example, in the case of nonsevere MS with symptoms,
a signiﬁcant SPAP increase at this stage strengthens a
diagnosis of severe MS in case of signiﬁcant mitral
valve gradient rise at peak. In the case of severe MR
without symptoms, LV systolic function assessment
to estimate existence of contractile reserve is per-
formed at this stage.
IMAGE OPTIMIZATION. Contrast administration is
usually avoided because of Doppler aliasing and
noise. An exception can be made if decision-making
depends mainly on accurate assessment of LVEF.
To allow LV systolic function assessment, either
with 3-dimensional LVEF or speckle tracking–derived
global longitudinal strain, low workload imagesTABLE 4 Sequence of Image Acquisition According to VSE Indication
Symptomatic patient
Nonsevere MR Color ﬂow Doppler (to assess MR
TR CW Doppler for SPAP, LV v
Pulmonary edema LV views, color ﬂow Doppler to de
Mild MR before CABG Color ﬂow Doppler (to assess MR
TR CW Doppler for SPAP, LV v
Nonsevere MS TR CW Doppler for SPAP, MS CW
Nonsevere AR LV views, TR CW Doppler for SPAP
Nonsevere/paradoxical low-ﬂow AS AV CW Doppler, LVOT PW Dopple
Equivocal AV PPM/stenosis AV CW Doppler, LVOT PW Dopple
Equivocal MV PPM/stenosis TR CW Doppler for SPAP, MS CW
Asymptomatic patient
Severe MR TR CW Doppler for SPAP, LV view
Signiﬁcant MS TR CW Doppler for SPAP, MS CW
Severe AR LV views, TR CW Doppler for SPAP
Severe AS LV views, TR CW Doppler for SPAP
Low LVEF
Low-ﬂow AS AV CW Doppler, LVOT PW Dopple
Low-ﬂow AV prosthesis AV CW Doppler, LVOT PW Dopple
CW ¼ continuous wave; LVOT ¼ left ventricular outﬂow tract; PISA ¼ proximal isovelocit
in Tables 1 and 2.should be acquired at a heart rate <100 to 110 beats/
min. The higher the heart rate, the higher the optimal
frame rate (or volume rate) for image acquisition.
Optimization is obtained by reducing the depth of
acquisition to include the LV only, minimizing the
sector width, and, for 3-dimensional imaging, using
multicycle acquisition.
A suboptimal frame rate can also limit the quality
of color ﬂow Doppler images; therefore, a narrow
sector and lower possible depth acquisition is rec-
ommended with zoom images being used for mea-
surements (e.g., proximal isovelocity surface area
radius in MR) to minimize errors. For proximal iso-
velocity surface area measurements, color ﬂow
Doppler images need a baseline shift, which may have
to be performed before acquisition if not feasible off-
line with the echocardiographic machine used.
To minimize measurement errors, spectral Doppler
traces should be acquired at maximum speed and
minimum scale, which allows good trace deﬁnition
without aliasing. To avoid missing the peak, the scale
has to be increased on exertion in expectation of
higher velocities. Heart translation with accelerated
respiration and movement of the chest wall during
exertion make image acquisition challenging, and it is
rare to obtain a complete series of Doppler traces
throughout the respiratory cycles. Doppler traces
from the parasternal window are affected to a larger
extent, making them unreliable during exertion. For
example, even if at rest the maximum tricuspidImage Acquisition Sequence
PISA, vena contracta, regurgitant jet), MR CW Doppler for PISA,
iews
tect MR
PISA, vena contracta, regurgitant jet), MR CW Doppler for PISA,
iews
Doppler for gradient
, color ﬂow Doppler to detect MR
r, LV views, LVOT view (baseline only)
r, LV views, LVOT view (baseline only), color ﬂow Doppler to detect MR
Doppler for gradient
s
Doppler for gradient
, color ﬂow Doppler to detect MR
, AV CW Doppler, LVOT PW Doppler, color ﬂow Doppler to detect MR
r, LV views, LVOT view (baseline only)
r, LV views, LVOT view (baseline only)
y surface area; PW ¼ pulsed wave; TR ¼ tricuspid regurgitation; other abbreviations as
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730regurgitation velocity may be obtained from the par-
asternal short-axis or right ventricular inﬂow view,
only velocities from apical 4-chamber views are usu-
ally accessible on exertion.
QUANTIFICATION. The amplitude of Doppler veloc-
ities depends on ﬂow alignment, which varies
signiﬁcantly on exertion from beat to beat. The
highest velocities, with better alignment, should be
used for measurements in sinus rhythm. An average
of 5 to 6 cardiac cycles can be used in atrial ﬁbrilla-
tion, for example, to estimate SPAP or mean mitral
valve gradient in MS. Nevertheless, it is challenging
to match averaged cycles between AV and LVOT
velocities for the use of continuity equation in AS.
LV assessment. LVEF can be estimated or calculated by
using 2-dimensional biplane or 3-dimensional
methods. 3D echocardiography can be used only at
baseline and at low workload when the heart rate is
still <100 to 110 beats/min and breath-holding
for multicycle acquisition might still be feasible.
The volume rate may be satisfactory with 1 cycle
acquisition when the left ventricle is small, ﬁtting
within a narrow sector width in all imaging planes.
Mitral valve assessment. The mean gradient is used to
assess MS severity, and MR quantiﬁcation is based on
the proximal isovelocity surface area method and on
the vena contracta width. The feasibility and repro-
ducibility of the proximal isovelocity surface area
method–based MR quantiﬁcation during exercise VSE
(9) was demonstrated in the laboratory of 1 of theTABLE 5 Minimum Report Content According to VSE Indication
Symptomatic patient Report relationship of symptoms w
Nonsevere MR Increase or not in MR severity, ma
absence of inducible ischemia
Pulmonary edema Presence or absence of inducible is
Nonsevere MS Findings-based MS severity  pulm
Nonsevere AR Contractile reserve, SPAP, inducibl
Nonsevere/paradoxical low-ﬂow AS AS severity, contractile reserve, pr
Equivocal AV PPM/stenosis AV PPM/stenosis severity, contract
absence of inducible MR, exert
Equivocal MV PPM/stenosis Findings-based MS severity  pulm
Asymptomatic patient Report observed symptomatic stat
Severe MR SPAP, contractile reserve
Mild MR before CABG Increase or not in MR severity, ma
absence of inducible ischemia
Signiﬁcant MS Findings-based MS severity  pulm
Severe AR Contractile reserve, SPAP, inducibl
Severe AS Contractile reserve, presence or ab
Low LVEF
Low-ﬂow AS AS severity, ﬂow reserve, presence
Low-ﬂow AV prosthesis AS severity, ﬂow reserve, presence
Abbreviations as in Tables 1 and 2.study authors (P.L.). The semiquantitative MR
severity assessment based on the MR jet area, not
reliable at rest, is even more misleading on exertion;
it underestimates MR severity in conditions of higher
left atrial pressure and fast heart rate for the frame
rate achieved.
AV assessment. Gradients (peak and mean) and calcu-
lated functional valve area should be quantiﬁed, both
at baseline and at peak in AS, because severity
grading is based on gradient rise with concomitant
valve area failure to increase during the test. Only the
apical window can be reliably used during exercise
VSE; therefore, if the highest AV velocities at rest are
obtained from the right parasternal window, a low-
dose dobutamine VSE is more appropriate because it
allows the use of this window throughout the test.
REPORTING GUIDE
In the absence of relative information in the existing
published data, the reporting guide describes the
clinical practice of the authors. A nonprescriptive
guide of minimum information to be included in the
report according to VSE indication is provided in
Table 5.
The exercise VSE report includes information
regarding achieved workload as an absolute value and
as a percentage of the maximum predicted workload.
The exercise tolerance of the patient is graded
considering not only the achieved workload but also
the usual level of activity (sedentary patients areReporting Guide
ith observed VSE-induced changes
ximum MR severity and SPAP, contractile reserve, presence or
chemia and ischemic MR
onary hypertension grading, gradient, exertion SPAP
e MR
esence or absence of inducible ischemia
ile reserve, presence or absence of inducible ischemia, presence or
ion SPAP
onary hypertension grading, gradient, exertion SPAP
us
ximum MR severity and SPAP, contractile reserve, presence or
onary hypertension grading, gradient, exertion SPAP
e MR
sence of inducible ischemia, presence or absence of inducible MR, SPAP
or absence of inducible ischemia
or absence of inducible ischemia
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731expected to perform less) and the type of disease.
Developed symptoms and the reason for termination
of the test are reported.
The dobutamine VSE report includes information
regarding dose and duration of dobutamine infusion,
developed symptoms, potential complications (e.g.,
arrhythmia, vaso-vagal), and the reason for termina-
tion of the test.
The description of ﬁndings is difﬁcult to stan-
dardize, and the characterization of disease is chal-
lenging, particularly in cases of >1 valve disease. In
self-declared “asymptomatic” patients, the observed
symptomatic status is reported. In self-declared
“symptomatic” patients, the relationship of symp-
toms with the observed VSE-induced changes is
reported, stating whether it is believed that the symp-
toms are due to the valve disease. Grading of valve
disease severity based on VSE ﬁndings is also reported.
CLINICAL IMPLEMENTATION OF RESULTS
Clinical management is tailored according to VSE-
diagnosed valve disease severity and symptomatic
status, as described in Table 6. Both ESC (dated 2012)
and ACC/AHA (dated 2014) guidelines (1,2) acknowl-
edge the VSE response as an indication for interven-
tion in a series of clinical scenarios.
SYMPTOMS DESPITE NONSEVERE VALVE DISEASE.
Symptomatic patients with VSE displaying only mild
to moderate disease should remain under surveil-
lance and their symptoms should be investigated as
noncardiac. Their follow-up should be performed at
time intervals deﬁned by the ESC (1) or ACC/AHA (2)
guidelines. In cases in which the symptoms persist
and a noncardiac cause was not found, it may be
reasonable to repeat the VSE at follow-up instead
of limiting the assessment to echocardiography at
rest.
Symptomatic patients with VSE displaying severe
disease are referred for intervention. Although both
the ESC and ACC/AHA guidelines recommend VSE in
symptomatic, nonsevere primary MR, only the ACC/
AHA guidelines (2) (published 2 years after the ESC
guidelines) clearly state that MR severity increases on
exertion to levels that explain the symptoms is an
indication for surgery. Nevertheless, for secondary
MR, the ESC guidelines (1) recommend mitral valve
surgery at the time of CABG, in case of shortness of
breath during exercise VSE with associated increase
in MR severity, and pulmonary hypertension.
Both the ESC and ACC/AHA guidelines (1,2)
recommend VSE for assessment of hemodynamic
signiﬁcance of MS in symptomatic patients, and in
both guidelines symptomatic severe MS is a Class Iindication for intervention. Consequently, symp-
tomatic patients with VSE-demonstrated severe MS
should be referred for intervention according to the
morphological characteristics of the valve. A valve
area <1.5 cm2 is the generally accepted anatomic
severity threshold for surgery (1,2); however, a valve
area >1.5 cm2 is an indication for intervention in the
ACC/AHA guidelines (2) in case of suitability for
percutaneous balloon valvotomy.
In symptomatic patients with moderate AR, VSE-
demonstrated LV contractile reserve, and lack of
inducible ischemia, induced MR or pathologic SPAP
increases are reassuring. Although further evidence
is needed, in the authors’ clinical practice, an
abnormal VSE response prompts case discussion by
the heart valve team. VSE-demonstrated severe AS
in symptomatic patients with paradoxical low-ﬂow
AS is a Class IIa indication for surgery in both guide-
lines (1,2).
In the case of prosthetic valves, the clinical
implementation mirrors the management of the
respective valve. Symptomatic patients with VSE-
demonstrated severe prosthetic valve dysfunction
and hemodynamic consequences require reinterven-
tion. Considering the higher surgical risk at reinter-
vention, the limited evidence, and the existing
controversy, it is appropriate, in the authors’ experi-
ence, to use a case-by-case approach with discussion
by the heart valve team.
ASYMPTOMATIC SIGNIFICANT VALVE DISEASE.
Symptomatic severe MR is a Class I indication for
surgery in both the ESC and ACC/AHA guidelines
(1,2); therefore, demonstration of symptoms during
exercise VSE in self-declared “asymptomatic” pa-
tients with severe MR is a robust surgical indication.
The ESC guidelines (1) recognize exertion-induced
SPAP increase to >60 mm Hg as a Class IIb indica-
tion for surgery in asymptomatic severe MR, in cases
of high likelihood of durable repair and low surgical
risk. No recommendation based on an exercise-
induced SPAP increase exists in the current ACC/
AHA guidelines (2). There is evidence that the lack of
LV contractile reserve during VSE predicts a drop in
LVEF at follow-up, which is associated with func-
tional capacity deterioration in conservatively treated
patients (26,27) and post-operative LV systolic
dysfunction and lower event-free survival in surgi-
cally treated patients (28). LV systolic dysfunction is a
Class I surgical indication in asymptomatic patients
with severe MR; although VSE is recommended
in these patients by the ESC guidelines (1), thus
acknowledging the role of contractile reserve and
speckle tracking global longitudinal strain in early
detection of LV systolic dysfunction, no clear
TABLE 6 Clinical Implementation of Results According to VSE Indication
VSE Result Clinical Implementation of Results (Ref. #)
Symptomatic patient
Nonsevere MR Nonsevere MR Medical management
Severe MR Surgical indication (2)
Pulmonary edema Inducible ischemia  MR Revascularization  MV repair
Mild MR before CABG No dynamic MR CABG only
Dynamic MR þ SPAP rise CABG þ MV repair (1)
Nonsevere MS Nonsevere MS Medical management
Severe MS Intervention, class I indication (1,2)
Nonsevere AR Normal response Medical management
Abnormal response Case discussion by the heart valve team
Nonsevere AS Nonsevere AS Investigate symptoms as noncardiac
Severe AS Intervention, class I indication (1,2)
Paradoxical low-ﬂow AS Nonsevere AS Medical management
Severe AS Intervention, class IIa indication (1,2)
Equivocal PPM/stenosis Nonsevere PPM/stenosis Medical management
Severe PPM/stenosis Case discussion by the heart valve team considering intervention
Asymptomatic patient
Severe MR Symptoms Surgery, class I indication (1,2)
No symptoms þ normal VSE Review at 6 months
No symptoms þ SPAP >60 mm Hg Repair if durable low-risk, class IIb indication (1)
No symptoms þ no LV CR Case discussion by the heart valve team considering intervention
Signiﬁcant MS Symptoms Intervention, class I indication (1,2)
No symptoms Hemodynamically signiﬁcant MS may need intervention
before noncardiac surgery or pregnancy planning
Severe AR Symptoms Surgery, class I indication (2)
No symptoms Review at 6 months
No symptoms þ no LV CR Close surveillance
Severe AS Symptoms Intervention, class I indication (1,2)
No symptoms þ normal VSE Review at 6 months
No symptoms þ blood pressure drop Intervention, class IIa indication (1,2)
No symptoms þ mean gradient rise >20 mm Hg Intervention, class IIb indication (1)
Low LVEF
Low-ﬂow AS Nonsevere AS Medical management
Severe AS þ ﬂow reserve Intervention, class IIa indication (1,2)
Severe AS þ no ﬂow reserve Intervention, class IIb indication (1)/class IIa indication (2)
CR ¼ contractile reserve; other abbreviations as in Tables 1 and 2.
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732indication for surgery is stated based on the results.
In the authors’ clinical practice, however, a lack of LV
contractile reserve triggers a case discussion by the
heart valve team, taking into consideration the suit-
ability of valve morphology for repair, surgical risk,
local repair success rate, and surgical mortality rate.
Wait times for intervention are also considered
because of the high probability of hemodynamic
decompensation within 6 months (26,27).
Severe MS with demonstrated symptoms and
limited exercise tolerance is a Class I indication for
intervention in both the ESC and ACC/AHA guidelines
(1,2); the type of intervention selected is based on
the morphological characteristics of the valve.
Although symptomatic severe AR is a Class I indi-
cation for surgery in both ESC and ACC/AHAguidelines, demonstration of symptoms during VSE
in asymptomatic patients may be an indication for
surgery (as recommended by the ACC/AHA guide-
lines). In patients with preserved exercise tolerance,
in the authors’ practices, VSE-demonstrated lack
of LV contractile reserve prompts close clinical
surveillance.
Both the ESC and the ACC/AHA guidelines (1,2)
clearly state that demonstration of symptoms during
exercise VSE is a Class I indication for intervention in
severe AS. Furthermore, in both guidelines, blood
pressure drop on exertion is a Class IIa surgical indi-
cation. Although both guidelines recognize the prog-
nostic value of a VSE-demonstrated >20 mm Hg mean
gradient rise, only the ESC guidelines (1) state that
this is a Class IIb surgical indication.
CENTRAL ILLUSTRATION Valvular Stress Echocardiography Guide For Referral, Procedure, Reporting, and Clinical Implementation
of Results
This table combines the essential information from the VSE guide tables. It can be printed and used as a poster guide in echocardiography laboratories and valve clinics.
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734VALVE DISEASE WITH REDUCED LV SYSTOLIC
FUNCTION. VSE-demonstrated severe AS in patients
with low-ﬂow, low-gradient AS is an indication for
intervention in both guidelines (1,2). The ACC/AHA
guidelines state this as a Class IIa indication (2). The
ESC guidelines differentiate the indication into Class
IIa in the presence of ﬂow reserve and Class IIb in its
absence (1).
GUIDELINES, EVIDENCE, AND
FURTHER RESEARCH NEEDS
Agreement between the current ESC and ACC/AHA
valve disease management guidelines reveals the VSE
indications supported by robust evidence at the
time of the publication of these guidelines, while
disagreement reveals the VSE indications in need for
either further research or appraisal of the later ac-
quired evidence.
SYMPTOMS DESPITE NONSEVERE VALVE DISEASE.
Both the ESC and the ACC/AHA valve disease man-
agement guidelines (1,2) recommend VSE and inter-
vention in VSE-demonstrated severe valve disease in
MS (Online Figures 1 to 7) and AS. The guidelines
differ in MR and AR.
In primary MR, both guidelines (1,2) recommend
VSE, but only the ACC/AHA guidelines (2) recommend
intervention in cases of severe MR. MR quantiﬁcation
is known to be challenging, particularly when the
MR jet is eccentric. Quantiﬁcation becomes even
more challenging on exertion and the evidence
regarding quantiﬁcation of MR severity changes
during VSE in primary MR is limited (9). Further
evidence is necessary in primary MR to corroborate
MR quantitative changes during VSE with catheteri-
zation ﬁndings on exertion and the clinical out-
come of patients with and without demonstrated
severe MR.
In unexplained pulmonary edema, only the ESC
guidelines (1) recommend VSE. Despite the lack of
evidence, this seems a reasonable VSE indication (8)
to exclude ischemia and ischemic MR. Nevertheless,
evidence is needed regarding the incidence of VSE-
demonstrated MR (or other hemodynamic changes)
in this setting.
Before CABG, only the ESC guidelines (1) recom-
mend MR assessment with VSE to inform decision-
making regarding concomitant mitral valve repair.
As described earlier in the Mitral Regurgitation sec-
tion, the RIME trial (10) provides evidence on this
topic. This trial reported mitral valve repair beneﬁt at
the time of CABG in patients with at least moderate
MR at rest or on exertion but did not speciﬁcally
address the role of VSE. For this assessment, a similarstudy would be needed, randomizing patients with at
least moderate MR on exertion only.
In AR, the ACC/AHA guidelines (2) recommend
exercise testing. There is no role for echocardiogra-
phy to regrade AR severity during exertion, because,
as described in the Aortic Regurgitation section, AR is
reduced with increases in heart rate.
ASYMPTOMATIC SIGNIFICANT VALVE DISEASE.
Both the ESC and the ACC/AHA valve disease man-
agement guidelines (1,2) recommend exercise testing
and intervention in cases of demonstrated symptoms
of MR, MS, and AS.
In MR, only the ESC guidelines (1) recommend
intervention (Class IIb indication) when SPAP is >60
mm Hg during VSE. Although there is evidence that
SPAP increases with exertion (25) can predict the
development of symptoms within 2 years, clinical
follow-up of patients with severe MR is performed at
shorter intervals. To a greater extent, SPAP >60
mm Hg on exertion is not unusual with age even in
the absence of MR (46). Consequently, further evi-
dence is needed to reﬁne this indication considering
age-related exertional SPAP and exertional SPAP
change at follow-up for the same patient.
Although there is evidence (26–28) that the lack of
LV contractile reserve predicts poor prognosis, no
relative indication for intervention exists. This mir-
rors skepticism regarding the ability of echocardiog-
raphy to accurately determine a small change in LVEF
(4%) and the limited data regarding global longitu-
dinal strain. Current evidence suggests at least the
need for further research regarding LV contractile
reserve in asymptomatic severe MR (27). The role of
3-dimensional echocardiography must also be inves-
tigated, considering its higher accuracy and repro-
ducibility in LVEF assessments.
In AS, both guidelines (1,2) also recommend inter-
vention in cases of blood pressure drop on exertion.
Nevertheless, only the ESC guidelines recommend
intervention (Class IIb) in cases of mean gradient
rise >20 mm Hg during VSE. There is evidence (36,37)
that this mean gradient rise confers poor prognosis
within 18 to 24 months, although clinical follow-up of
patients with severe AS is performed at shorter in-
tervals. Because samples used in the aforementioned
studies were small, further evidence is needed.
In AR, exercise testing to reveal symptoms is rec-
ommended only by the ACC/AHA guidelines (2), and
VSE is not recommended. The role of VSE in pre-
dicting LV systolic dysfunction has limited evidence
(29,30); considering the clinical implications of LV
systolic dysfunction in severe AR, it seems worth-
while to further investigate this VSE indication and
its impact on clinical outcomes.
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735VALVE DISEASE WITH REDUCED LV SYSTOLIC
FUNCTION. Both the ESC and the ACC/AHA valve
disease management guidelines (1,2) recommend VSE
and intervention in cases of demonstrated severe AS in
low-ﬂow, low-gradient AS with reduced LV systolic
function (Online Figures 8 to 13). The indication is
Class IIa in the ACC/AHA guidelines regardless of ﬂow
reserve status but Class IIb in the ESC guidelines in
cases of lack of demonstrated ﬂow reserve. In support
of the ACC/AHA guidelines, there is evidence that the
VSE-demonstrated lack of ﬂow reserve does not pre-
dict lack of LVEF recovery (47), and, furthermore,
there is evidence that clinical outcome is improved
by aortic valve replacement in patients with VSE-
demonstrated lack of ﬂow reserve (48). Larger clin-
ical outcome studiesmay shedmore light on this topic.CONCLUSIONS
VSE is an important clinical tool in the assessment
and management planning of patients with valve
disease. The technique is being perfected in high-
volume centers, and the applications are continu-
ously evolving (Central Illustration). Nevertheless,
further evidence is needed with regard to many VSE
indications and the outcome-based clinical imple-
mentation of results.
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